# Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis

> **NCT00958035** · PHASE4 · COMPLETED · sponsor: **Allergan** · enrollment: 89 (actual)

## Conditions studied

- Hypotrichosis

## Interventions

- **DRUG:** bimatoprost ophthalmic 0.03% solution
- **DRUG:** vehicle sterile solution (placebo)

## Key facts

- **NCT ID:** NCT00958035
- **Lead sponsor:** Allergan
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-11
- **Primary completion:** 2010-07
- **Final completion:** 2010-08
- **Target enrollment:** 89 (ACTUAL)
- **Last updated:** 2012-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00958035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00958035, "Study of Bimatoprost Solution in Increasing Eyelash Prominence in African Americans With Eyelash Hypotrichosis". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00958035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*